Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: Relation to maternal and neonatal characteristics

Journal of Clinical Biochemistry and Nutrition

Volumn 52, Issue 1, 2013, Pages 27-31

  Nakatsukasa, Yoko ^a,b   Tsukahara, Hirokazu ^b   Tabuchi, Kazuhisa ^a   Tabuchi, Masako ^a   Magami, Tomoko ^a   Yamada, Mutsuko ^b   Fujii, Yosuke ^b   Yashiro, Masato ^b   Tsuge, Mitsuru ^b   Morishima, Tsuneo ^b  

^a Perineito Hahatokono Hospital for Mothers and Children   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Later pregnancy; Oxidative stress; Redox potential; Thioredoxin; Total hydroperoxides

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; HYDROPEROXIDE; THIOREDOXIN 1; URIC ACID;

ADULT; APGAR SCORE; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PREGNANCY OUTCOME; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY;

EID: 84872316085     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-71     Document Type: Article

References (38)

1. Tsukahara H. Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem 2007; 14: 339-351.
2. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122: 369-382. (Pubitemid 39506594)
3. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 2002; 57: 609-613. (Pubitemid 35316977)
4. Belo L, Caslake M, Santos-Silva A, et al. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004; 177: 391-399. (Pubitemid 39505273)
5. Kodama H, Shinohara H, Nukazuka A, Narita Y, Yoshida M. Implications of an oxidative stress marker, serum hydroxyperoxide concentration, in the medical checkup of pregnant women at around 30 weeks of gestation. Maternal Health 2008; 49: 98-106 (Japanese).
6. Hung TH, Lo LM, Chiu TH, et al. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reprod Sci 2010; 17: 401-409.
7. Siddiqui IA, Jaleel A, Tamimi W, Al Kadri HM. Role of oxidative stress in the pathogenesis of preeclampsia. Arch Gynecol Obstet 2010; 282: 469-474.
8. Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010; 42: 1634-1650.
9. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997; 15: 351-369. (Pubitemid 27169285)
10. Nakamura H, Hoshino Y, Okuyama H, Matsuo Y, Yodoi J. Thioredoxin 1 delivery as new therapeutics. Adv Drug Deliv Rev 2009; 61: 303-309.
11. Mitsui A, Hamuro J, Nakamura H, et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 2002; 4: 693-696. (Pubitemid 35001454)
12. Takagi Y, Mitsui A, Nishiyama A, et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999; 96: 4131-4136. (Pubitemid 29169048)
13. Shioji K, Kishimoto C, Nakamura H, et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002; 106: 1403-1409. (Pubitemid 35013046)
14. Kasuno K, Nakamura H, Ono T, Muso E, Yodoi J. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int 2003; 64: 1273-1282. (Pubitemid 37153792)
15. Kobayashi F, Sagawa N, Nanbu Y, et al. Biochemical and topological analysis of adult T-cell leukaemia-derived factor, homologous to thioredoxin, in the pregnant human uterus. Hum Reprod 1995; 10: 1603-1608.
16. Di Trapani G, Perkins A, Clarke F. Production and secretion of thioredoxin from transformed human trophoblast cells. Mol Hum Reprod 1998; 4: 369-375. (Pubitemid 28228533)
17. Ejima K, Nanri H, Toki N, Kashimura M, Ikeda M. Localization of thioredoxin reductase and thioredoxin in normal human placenta and their protective effect against oxidative stress. Placenta 1999; 20: 95-101. (Pubitemid 29039256)
18. Fujii S, Nanbu Y, Konishi I, Mori T, Masutani H, Yodoi J. Immunohistochemical localization of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in human fetal tissues. Virchows Arch A Pathol Anat Histopathol 1991; 419: 317-326.
19. Matsui M, Oshima M, Oshima H, et al. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 1996; 178: 179-185. (Pubitemid 26297250)
20. Umekawa T, Sugiyama T, Kihira T, et al. Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism. Endocrinology 2008; 149: 3980-3988.
21. Kamimoto Y, Sugiyama T, Kihira T, et al. Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy. Diabetologia 2010; 53: 2046-2055.
22. Ezaki S, Suzuki K, Kurishima C, et al. Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. J Clin Biochem Nutr 2009; 44: 111-118.
23. Todoroki Y, Tsukahara H, Ohshima Y, et al. Concentrations of thioredoxin, a redox-regulating protein, in umbilical cord blood and breast milk. Free Radic Res 2005; 39: 291-297. (Pubitemid 40439391)
24. Nojima J, Miyakawa M, Kodama M, et al. Measurement of the oxidation stress degree by the automated analyzer JCA-BM 1650. Jpn J Med Technol 2010; 59: 199-207 (Japanese).
25. Hussein MH, Hashimoto T, Daoud GA, et al. Oxidative stress after living related liver transplantation subsides with time in pediatric patients. Pediatr Surg Int 2011; 27: 17-22.
26. Itabashi K, Fujimura M, Kusuda S, et al. New birth size standards by gestational age for Japanese neonates. J Jpn Soc Pediatr 2010; 114: 1271-1293 (Japanese).
27. Kuroda S, Watanabe M, Santo T, et al. Postpartum increase of serum thioredoxin concentrations and the relation to CD8 lymphocytes. Ann Clin Biochem 2010; 47: 62-66.
28. Pasalic D, Marinkovic N, Feher-Turkovic L. Uric acid as one of the important factors in multifactorial disorders - facts and controversies. Biochem Med (Zagreb) 2012; 22: 63-75.
29. Kaneko K, Kimata T, Tsuji S, Shimo T, Takahashi M, Tanaka S. Serum albumin level accurately reflects antioxidant potentials in idiopathic nephritic syndrome. Clin Exp Nephrol 2012; 16: 411-414.
30. Rogers MS, Wang CC, Tam WH, Li CY, Chu KO, Chu CY. Oxidative stress in midpregnancy as a predictor of gestational hypertension and pre-eclampsia. BJOG 2006; 113: 1053-1059. (Pubitemid 44310098)
31. Potdar N, Singh R, Mistry V, et al. First-trimester increase in oxidative stress and risk of small-for-gestational-age fetus. BJOG 2009; 116: 637-642.
32. Min J, Park B, Kim YJ, Lee H, Ha E, Park H. Effect of oxidative stress on birth sizes: consideration of window from mid pregnancy to delivery. Placenta 2009; 30: 418-423.
33. Shibata E, Ejima K, Nanri H, et al. Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 2001; 22: 566-572. (Pubitemid 32700841)
34. Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004; 444: 49-55. (Pubitemid 38200090)
35. Iwai T, Fujii S, Nanbu Y, et al. Expression of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in the human ovary throughout the menstrual cycle. Virchows Arch A Pathol Anat Histopathol 1992; 420: 213-217.
36. Maruyama T, Kitaoka Y, Sachi Y, et al. Thioredoxin expression in the human endometrium during the menstrual cycle. Mol Hum Reprod 1997; 3: 989-993. (Pubitemid 127509965)
37. Sahlin L, Stjernholm Y, Holmgren A, Ekman G, Eriksson H. The expression of thioredoxin mRNA is increased in the human cervix during pregnancy. Mol Hum Reprod 1997; 3: 1113-1117. (Pubitemid 127509917)
38. Clarke FM, Orozco C, Perkins AV, et al. Identification of molecules involved in the 'early pregnancy factor' phenomenon. J Reprod Fertil 1991; 93: 525-539.